Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity

Diabetologia
T GylvinF Pociot

Abstract

Beta cell loss in Type 1 and Type 2 diabetes mellitus may result from apoptosis and necrosis induced by inflammatory mediators. The suppressor of cytokine signalling (SOCS)-3 is a natural inhibitor of cytokine signalling and also influences insulin signalling. SOCS3 could therefore be a candidate gene in the development of Type 1 and Type 2 diabetes mellitus. Mutation analysis of the SOCS3 gene was performed in 21 patients with Type 1 diabetes mellitus and in seven healthy subjects. An identified promoter variant was examined in (i) 250 families with Type 1 diabetic family members (1097 individuals); (ii) 212 glucose-tolerant first-degree relatives of Type 2 diabetic patients; and (iii) 370 population-based young, healthy subjects who were unrelated. Three mutations were identified in the promoter region, but none in the coding region or the 3'UTR. Two of the three mutations had allele frequencies below 1% whereas the C -920-->A substitution had a minor allele frequency of 8%. In the group of young healthy subjects the insulin sensitivity index was higher among homozygous carriers of the A-allele than among heterozygous and wild-type subjects ( p=0.027, uncorrected). The same trend was found in the group of first-degree relativ...Continue Reading

References

Aug 1, 1990·Experimental and Clinical Endocrinology·A LugerG Schernthaner
Sep 1, 1994·Diabetologia·J NerupT Lorenzen
Jan 1, 1996·Annual Review of Medicine·C R KahnA Doria
Jun 26, 1997·Nature·R StarrD J Hilton
Apr 16, 1998·American Journal of Human Genetics·R S Spielman, W J Ewens
Mar 7, 2001·Nature Medicine·K AlmindC R Kahn
Mar 10, 2001·Recent Progress in Hormone Research·P Froguel, G Velho
Apr 5, 2001·American Journal of Physiology. Cell Physiology·F KimM A Corson
Jun 9, 2001·The Journal of Clinical Endocrinology and Metabolism·J JohannesenUNKNOWN Danish Study Group of Diabetes in Childhood. The Danish Insulin-dependent Diabetes Mellitus Epidemiology and Genetics Group
Sep 13, 2001·Stem Cells·D L Krebs, D J Hilton
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·A E KarlsenN Billestrup
Apr 5, 2002·Genome Research·Rolf Ohlsson, Chandrasekhar Kanduri
Aug 13, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Robert F Grimble
Sep 14, 2002·The Journal of Biological Chemistry·Liangyou RuiMorris F White
Dec 28, 2002·Diabetes·Alexandra E ButlerPeter C Butler
Feb 13, 2003·Science's STKE : Signal Transduction Knowledge Environment·Danielle L Krebs, Douglas J Hilton
Apr 30, 2003·Diabetes Care·Katherine EspositoDario Giugliano
Mar 11, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·Z M LarsenUNKNOWN Danish Study Group of IDDM in Childhood

❮ Previous
Next ❯

Citations

Jan 4, 2008·Acta Physiologica·P Lebrun, E Van Obberghen
May 19, 2010·Biomarkers in Medicine·Neeraj KumarNarinder Mehra
Mar 9, 2012·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M L TellecheaG Frechtel
Mar 7, 2014·European Journal of Immunology·Yan LiangDong-Qing Ye
Jan 22, 2013·Cell Biochemistry and Function·Dariusz SuchyBogusław Okopień
Apr 29, 2005·Diabetes/metabolism Research and Reviews
Jan 24, 2006·International Journal of Immunogenetics·R NiT Hara
Jan 30, 2007·Diabetes·Sif G RønnThomas Mandrup-Poulsen
Dec 13, 2005·Molecular and Cellular Biochemistry·Muthuswamy BalasubramanyamViswanathan Mohan
Jan 15, 2014·Molecular Biology Reports·Xiaotao FengQiuyan Jiang
Nov 3, 2020·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mahsa RezaeepoorMahdi Behzad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis